PSVT

Milestone Enrolls First Canadian Patient in ReVeRA-301

MONTREAL and CHARLOTTE, N.C. — September 24, 2026 Milestone Pharmaceuticals Inc. announced that the Montreal Heart Institute has enrolled...

By cGxPwire Editor
September 25, 2026

Bio-Pharma

Milestone Pharmaceuticals Secures First Overseas Etripamil Approval

Montreal, Quebec, and Charlotte, North Carolina — September 3, 2026 Milestone Pharmaceuticals announced that China’s National Medical Products Administration...

By cGxPwire Editor
September 4, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

PSVT

Milestone Enrolls First Canadian Patient in ReVeRA-301

Milestone Pharmaceuticals Secures First Overseas Etripamil Approval